Neoadjuvant chemotherapy for locally advanced colonic cancer is the standard of care.

Recently completed multi-national trials have demonstrated major patient benefits from neoadjuvant therapy from colon cancer. It is now timely to institute these treatment pathways in our MDTs for the benefit of our patients.